The Fort Worth Press - FriskaAi and Dexcom Enter CGM Data Integration Agreement

USD -
AED 3.672498
AFN 64.999682
ALL 81.827235
AMD 365.160186
ANG 1.789785
AOA 917.999742
ARS 1544.481598
AUD 1.46107
AWG 1.8
AZN 1.706428
BAM 1.762379
BBD 2.036128
BDT 126.028385
BGN 1.747831
BHD 0.381383
BIF 3024.210446
BMD 1
BND 1.292395
BOB 11.989636
BRL 5.583699
BSD 1.010945
BTN 95.007435
BWP 13.869176
BYN 3.0269
BYR 19600
BZD 2.033164
CAD 1.426105
CDF 2314.999732
CHF 0.833275
CLF 0.024992
CLP 983.609895
CNY 6.67035
CNH 6.66699
COP 3280.9
CRC 457.263359
CUC 1
CUP 24.260419
CVE 99.36917
CZK 22.02055
DJF 180.019916
DKK 6.750195
DOP 61.316908
DZD 136.897983
EGP 53.547704
ERN 15
ETB 164.541452
EUR 0.902992
FJD 2.26815
FKP 0.753031
GBP 0.754375
GEL 2.598309
GGP 0.753031
GHS 11.838234
GIP 0.753031
GMD 73.999988
GNF 8956.017465
GTQ 7.724958
GYD 211.837332
HKD 7.84405
HNL 27.174457
HRK 6.76901
HTG 132.510848
HUF 329.413982
IDR 18235.95
ILS 3.174849
IMP 0.753031
INR 93.831985
IQD 1532.417211
IRR 1906074.999698
ISK 123.350474
JEP 0.753031
JMD 160.446988
JOD 0.708962
JPY 159.782495
KES 129.960042
KGS 87.449603
KHR 4122.94022
KMF 442.000317
KPW 899.999961
KRW 1332.774996
KWD 0.31137
KYD 0.842352
KZT 451.299842
LAK 22755.230323
LBP 90528.995629
LKR 335.972315
LRD 171.855991
LSL 16.573648
LTL 2.95274
LVL 0.60489
LYD 6.480393
MAD 9.86162
MDL 18.166334
MGA 4574.394744
MKD 55.575371
MMK 2099.724407
MNT 3604.903758
MOP 8.167515
MRU 40.781511
MUR 47.169835
MVR 15.399797
MWK 1752.977277
MXN 18.605976
MYR 4.081897
MZN 63.89969
NAD 16.571931
NGN 1345.740046
NIO 37.201087
NOK 9.569402
NPR 152.012581
NZD 1.797825
OMR 0.384506
PAB 1.010972
PEN 3.44501
PGK 4.540191
PHP 63.663007
PKR 277.574021
PLN 3.983398
PYG 6240.678409
QAR 3.685126
RON 4.827105
RSD 106.191869
RUB 83.07543
RWF 1495.696841
SAR 3.772213
SBD 8.090747
SCR 13.937946
SDG 601.50203
SEK 9.985755
SGD 1.285215
SHP 0.749316
SLE 22.902058
SLL 20969.504398
SOS 577.749741
SRD 37.645974
STD 20697.981008
STN 22.079133
SVC 8.845235
SYP 13001.999685
SZL 16.578126
THB 33.783503
TJS 9.290497
TMT 3.5
TND 3.012932
TOP 2.40776
TRY 50.261103
TTD 6.855598
TWD 32.930497
TZS 2658.158982
UAH 45.980237
UGX 4124.816943
UYU 40.90479
UZS 12104.528047
VES 900.490495
VND 25682
VUV 119.943861
WST 2.787799
XAF 592.324219
XAG 0.019376
XAU 0.000251092251
XCD 2.70255
XCG 1.821762
XDR 0.707052
XOF 592.324219
XPF 107.465645
YER 236.503327
ZAR 16.6022
ZMK 9001.199211
ZMW 20.597486
ZWL 321.999592
SSP 5786.523514
MXV 2.090565
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

FriskaAi and Dexcom Enter CGM Data Integration Agreement
FriskaAi and Dexcom Enter CGM Data Integration Agreement

FriskaAi and Dexcom Enter CGM Data Integration Agreement

ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into the FriskaAi platform. Under the agreement, data from Dexcom CGMs will be integrated with Friska Ai, the company's groundbreaking AI-powered healthcare platform supporting physicians and patients with actionable personalized care management programs.

Text size:

FriskaAi is a physician-directed health and wellness platform that supports the management of diabetes and other chronic diseases by helping providers take an evidence-based approach to preventive care. The EHR-agnostic FriskaAi platform leverages advanced AI and mobile technology to generate personalized health insights and recommendations, empowering patients to take control of their health journey in partnership with their clinical team.

"Impacting more than 38 million Americans, diabetes has emerged as a major public health problem, and its effective management has become a foundational element of preventive medicine," says Shaji Nair, CEO of FriskaAi. "Dexcom's pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions. FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness."

Dexcom CGMs use a small, wearable sensor to continuously measure and send glucose levels wirelessly to a smart device or receiver in real-time, without the need for fingerpricks. Dexcom CGMs also offer a suite of customizable alerts that can warn of high or low glucose levels and send predictive alerts to help users spend more time in range.

The FriskaAi mobile app securely integrates with Dexcom CGMs and other smart devices, as well as health apps, for analysis by the powerful HIPAA-compliant FriskaAi platform. That data, along with other clinical data and studies, is continuously monitored by sophisticated AI-powered algorithms that alert the patient when action is recommended and generate actionable reports for use by the clinician at the point of care to inform care decisions.

Aggregated health data is also analyzed within the FriskaAI platform to help physicians identify trends and risks within their patient populations, enabling more proactive and preventive care strategies.

About FriskaAi

FriskaAi is a powerful AI-enabled EHR-agnostic platform that helps physicians and other providers take an evidence-based approach to preventive care. The physician-initiated platform leverages advanced AI- and mobile technology to provide patients with personalized health insights and recommendations, empowering them to take control of their health journey in partnership with their clinical team. This aggregated health data, including information from patients' glucometers, other smart devices, and health apps, is continuously analyzed by advanced evidence-based algorithms that alert the patient when action is needed and provide clinicians with actionable reports to inform care decisions. FriskaAi also supports population health strategies by analyzing aggregated health data to identify trends and risks within a defined patient population. For more information, visit www.friska.ai.

Media Contact:
Michele Nachum
NPC Creative Services
[email protected]

SOURCE: FriskaAi



View the original press release on ACCESS Newswire

X.Silva--TFWP